Key Metrics
Journal Specifications
- PublisherLIPPINCOTT WILLIAMS & WILKINS
- LanguageEnglish
- FrequencyMonthly
- LanguageEnglish
- FrequencyMonthly
- Publication Start Year1975
- Publisher URL
- Website URL
Ready to spotlight your research findings?
Impress peers and journals alike with a concise, visual summary of your work.
Months | % Papers published |
---|---|
0-3 | 11% |
4-6 | 32% |
7-9 | 40% |
>9 | 17% |
Topics Covered
Year-wise Publication
- 5Y
- 10Y
FAQs
Since when has Pain been publishing? 
The Pain has been publishing since 1975 till date.
How frequently is the Pain published? 
Pain is published Monthly.
Who is the publisher of Pain? 
The publisher of Pain is LIPPINCOTT WILLIAMS & WILKINS.
How can I view the journal metrics of Pain on editage? 
For the Pain metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of Pain? 
The eISSN number is 1872-6623 and pISSN number is 0304-3959 for Pain.
What is the focus of this journal? 
The journal covers a wide range of topics inlcuding Migraine, Spina bifida, Chronic pain, Clinical trial, Neuropathic pain, Opioid, Complex regional pain syndrome, Amygdala, Back pain, Proteasome, Sensitization, Hyperalgesia, Ultraviolet, Heat shock protein, Randomized controlled trial, Cannabinoid, Persistent pain, Aerobic exercise, Low back pain, Reactive oxygen species.
Why is it important to find the right journal for my research? 
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career? 
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only? 
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.